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1031-84 T Cell Secreted interferon-Gamma Mediates the Repair 
Response to Arterial injury: Studies on Immune- 
Deficient Rag-1 KO Mice 
Honovan Li, Paul Dimayuga, Taleo Anazawa, Juliana Yano, Jan Nilsson, Kuang-Yuh 
Chyu, Prediman K. Shah, Bojen Cercek, Cedars-Sinai Medical Center, Los Angeles, 
Cafifornia, Lund University, Malmo, Sweden. 
Sackgreund: Arterial injury initiates an immune-modulated response but serum levels of 
interferon-~' (IFN~) after injury has not been characterized. We tested the effect of adop- 
tive transfer of T cells from wild type mice or administration of exogenous IFN-y on the 
response to injury in B and T cell deficient Rag-1 KO mice. 
Methods: Carotid artery cuff injury was induced in Rag-1 KO and wild type mice. Serum 
IFN-~, levels were quantified by ELISA. T cell enriched splenocytes from wild type mice 
were injected i.v. (2-4 x 107 cells) into Rag-1 KO mice 48 hours prior to injury. Another 
group of Rag-KO mice was injected with murine IFN-~, (20, 000 units, every other day) 
starting on the day of injury. Neointimal area was measured 21 days after injury. 
Results: Basal serum IFN-y in wild type mice was 297.8_+123.4 pg/ml (n--4), and unde- 
tectable in 3 of 4 mice tested 24 hours after injury. IFN-~' levels returned to baseline levels 
3 days after injury (272_+195.5 pg/ml; n=3). Rag-1 KO mice had low levels of IFN-~' 
(44.3+41.8 pg/ml; n=3), which was increased after adoptive T cell transfer (464.5_+404.2 
pg/ml; n=4) indicating that the T cells were viable. 
Neointimal area in microns eq: 
Group Rag-1 KO Rag-1 KO+T Rag-1 KO+IFN 
Neointimal area 22 +/- 8.1 9.2 +/- 5.8 4.3 +/- 1.6 
*p<0.05 vs. Rag-1 KO 
Rag-1 KO+T= Rag-1 KO mice with T cell transfer 
Rag-1 KO+IFN= Rag-1 KO mice treated with IFN-y 
Conclusion: These results suggest that adoptive T cell transfer in Rag-1 KO mice leads 
to increased basal IFN-y and reduces neointimal formation in response to injury. Exoge- 
nous IFN-7 could be a useful adjunctive measure in modulating the repair response to 
arterial injury. 
1031-85 A Potential Protective Role of Heat Shock Protein 70 in 
Atherogeneais 
Jianhui Zhu. Arshed A. Quyyumi, Hongsheng Wu, David Rott, Alexandra Zalles-Ganley, 
Jibike Ogunmakinwa, Stephen E. Epstein, Washington Hospital Center, Washington, 
Dish of Columbia, National Institutes of Health, Bethesda, Maryland. 
Background: Heat shock proteins (HSPs) constitute a large family of ubiquitous mole- 
cules, highly conserved across species that aid in a cell's response to stress. Despite 
their important beneficial cellular functions, one of these molecules, HSP60, appears to 
serve as a target for autoimmune mechanisms involved in atheregenesis and thereby 
may contribute to athe~'osclerosis. Experimental evidence suggests a cardioprotactive 
role of another member of HSPs, HSP70, in several examples of acute myocardial 
stress. We therefore examined whether HSP70 is associated with coronary artery dis- 
ease (CAD). Methods: Blood samples from 421 patients (62% men, mean age 57 years) 
evaluated for CAD by coronary angiography, were tested for human HSP70 antigen 
(ELISA). Results: Serum HSP70 was detectable in 67% of study subjects. Unlike HSP60, 
the levels of HSP70 negatively correlated with the prevalence of CAD (P=0.015). On 
multivariate logistical regression analysis, individuals with HSP70 levels above the 
medium (0.Sng/ml) had half the risk of CAD than individuals with levels below the 
medium, and that the association between elevated HSP70 levels and low CAD risk was 
independent of traditional CAD risk factors (P=0.011). A similar negative association 
between HSP70 levels and disease severity (number of diseased vessets) was also 
found (P=0.011). Interestingly, HSP70 also negatively correlated with CMV infection, 
even after adjustment for CAD risk factors and seropositivities to other infectious patho- 
gens (P=0.0086). (CMV IgG seropositivity was an independent predictor of CAD; 
adjusted OR 1.73, 95%CL 1.02-2.93). Conclusion: These data provide the first evidence 
that human HSP70 is a potent marker for lowered CAD susceptibility, presumably 
through its multiple protective effects on a cell's response to stress. These studies raise 
the possibility that increased expression of HSP70 in cells of the vessel wall may have 
protective effects against the development of atherosclerosis without, as opposed to 
HSP60, serving as a target for autoimmune responses that attenuate beneficial effects 
and that may even exacerbate disease development. 
1031-86 Oncostat in  M, a Member of IL-6 Fami ly  Cytokines, 
Induces MMP-9 Expression and Activation in Vascular 
Smooth Muscle Cells via ERK-Mediated Pathway 
Tsuvoshi Naoata, Hisashi Kai, Rei Shibata, Yayoi Yoshida, Kaoru Moriyama, Tsutomu 
Imaizumi, Kurume Universi~ Kurume, Japan, 
Background: Oncostatin M (OsM) is a member of IL-6 family cytokines, which is pro- 
duced by inflammatory cells, and regulates cell proliferation and/or the extracellular 
matrix metabolism in various tissues. Matrix metallopreteinase (MMP)-9 has been impli- 
cated in formation and unstabilization of atherosclerotic lesions by regulating the extra- 
cellular matrix degradation. Currently, little is known on the effects of OsM on vascular 
smooth muscle cells (VSMCs). Thus, we examined the OsM-mediatad intracellular sig- 
naling system and the roles of OsM in cultured VSMCs from rat aorta. 
Methods: Activation of ERK1/ERK2 or Star3 was determined on the basis of immunoblot- 
ring analysis. MMP-9 mRNA expression was evaluated by the Real-time RT-PCR analy- 
sis. MMP-9 Activity was evaluated by gelatin zymography. 
Results: OsM transiently induced BRK1/ERK2. phosphorylations after 2 min with a peak 
at 15 rain, returning to baseline by 60 min. Star3 was also transiently phosphorylatad by 
OsM in the similar time course. Effects of OsM on ERK1/ERK2 and star3 were dose- 
dependent of OsM (0.1-30 ng/mL). Real-time RT-PCR analysis showed that MMP-9 
mRNA expression was transiently upregulated by OsM with a peak at 4 hrs. Further- 
more, gelatin zymography revealed MMP-9 activity was increased in the conditioned 
medium obtained from the OsM-treated VSMCs. An ERK kinase inhibitor, PD98059, not 
only blocked the OsM-induced ERKI/ERK2 phosphorylations but also abolished the 
OsM-induced MMP-9 induction and activation. In contrast, overexpression of a dominant 
negative Star3 using an adenoviral vector had no effects on the OsM-induced MMP-9 
mRNA induction. OsM had no significant effects on the serum-induced VSMC prolifera- 
tion. 
Conclusion: OsM stimulated MMP-9 expression and activation through the ERK-medi- 
ated pathway in cultured VSMCs. These observations raise the possibility that the OsM- 
related mechanism is involved in the progression of the atherosclerosis and the plaque 
rupture by regulating the extracellular metabolism. 
1031-87 Matrix Metalloproteinase Inhibition Reduces Axial 
Tensile Strength in the Arterial Wall 
Marion J. Sierevooel. Evelyn Velema, Carolien J. van Andel, Manon Oude Nijhuis, Freek 
J. van der Meer, Chris L. de Korte, Chaylendra Strijder, Miriam B. Smeets, Dominique P. 
De Kleijn, Cornelius Borst, Gerard Pasterkamp, Dept of Cardiology, University Medical 
Center Utrecht, G02-523, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. 
Background. Matrix metallopreteinase (MMP) inhibitors are being tested in the preven- 
tion of restenosis. Their effect on the integrity of the normal and growing vessel wall is 
unknown. We studied the effect of MMP inhibition on arterial geometric growth, arterial 
compliance, tensile strength, collagen content and TGF-beta-I expression. Methods. 
Seventeen growing juvenile pigs and 12 mature pigs were treated with a non-selective 
MMP inhibitor (juvenile pigs: BB-2616, mature pigs: BB-2983) for 42 days or served as 
controls. Angiography was performed in peripheral arteries to assess arterial growth. 
Using 30 Mhz intravascular ultrasound, arterial compliance was determined in the exter- 
nal lilac arteries. In 4 right coronary arteries, two-dimensional stress-strain relationships 
were assessed. Collagen content was quantified in peripheral and coronary arteries 
using polarized light and digital image microscopy. TGF-beta-I mRNA expression was 
determined with semi-quantitative PCR. Results. Compliance did not differ among 
groups (p>0.05). However, tensile strength in axial, but not in circumferential direction 
was significantly reduced by MMP inhibition: axial stress 11.0 ± 4.2 (10E4 N/m2) at axial 
stretch of 60 % versus 54.3 ± 3.5 (10E4 N/m2) in the control group (p=0.001). No signifi- 
cant differences were observed in adventitial collagen content (p>0.07). Arterial geomet- 
ric growth was not affected by MMP inhibition: 12.2 ± 4.9 % versus 12.2 ± 1.3 % in the 
control group. MMP inhibition reduced TGF-beta-I expression by on average 42 % 
(p=0.01). Conclusions, MMP inhibition reduced both TGF-beta-I expression and axial 
tensile strength of the arterial wall without affecting collagen content. MMP inhibition may 
reduce axial tensile strength by reducing collagen cross-linking through inhibition of TGF- 
beta induced lysyloxidase activation. 
1031-88 PSGL-1 Blockade Using a Unique Monoclonal Antibody 
4RA10 Reduces Neointima Formation After Arterial 
Injury in Apolipoprotein-E Deficient Mice 
J William Phillios, Kurt G. Barringhaus, John M. Sanders, Ann C. Czarnik, Dietmar 
Vestweber, Klaus Ley, lan J. Sarembock, University of Virginia, Charlottesville, Virginia. 
Background: Emerging data suggests that P-selectin blockade may be important in lim- 
iting the response to vascular injury. P-selectin has been shown to mediate leukocyte- 
endothetium and ieukocyte-platelet interactions. These interactions are mediated 
through binding of P- selectin to P-selectin glycoprotein ligand-1 (PSGL-1) located on the 
surface of leukocytes. We tested the hypothesis that blockade of PSGL-1 using a unique 
blocking monoclonal antibody would result in reduced neointima formation following 
carotid denudation injury in apolipoprotein E (apoE-/-) mice fed a Western diet (WD). 
Methods: Female ApoE-/- mice (n=28) were fed a WD for one week prior to wire denu- 
dation of the left common carotid artery followed by four weeks of WD. Three hours prior 
to injury each mouse was given a single bolus of 100mg of rat antimouse blocking mono- 
clonal antibody to PSGL-1,4RA10, (n=12) or isotype control (n=16) via I P injection. Four 
weeks after injury, carotid arteries were removed, paraffin embedded and sectioned for 
histomorphometry 
Results: Neointima formation at 28 days was significantly reduced (58%) in the 100mg 
PSGL-1 antibody treated groups versus isotype controls (13000mm2 ± 3000 vs. 
31000mm2 ± 4000, p£0.001, n=28). Intima to media (I/M) ratios were also reduced (0.24 
± 0.06 vs. 0.60 ±0.01, p£0.01, n=28). 
Conclusions: Inhibition of leukocyte-endothelium and leukocyte-platelet interactions by 
PSGL-1 inhibition using a unique blocking monoclonal antibody, 4RA10, significantly lim- 
its neointima formation following carotid denudation injury at 28 days in the cholesterol- 
fed, apoE-/- mouse. 
1031-89 Enhancement of Calcium Sensitization Mediated by a 
Rho Associated Protein Kinase in Resistance Arteries 
Rats With Congestive Heart Failure 
Satsuki Koida, Mitsumasa Ohyanagi, Atsuncri Ueda, Eishin Shimizu, Tadaaki Iwasaki, 
Hyogo College of Medicine, Nishinomiya, Japan, 
Background. Although many studies suggest that enhanced contractile response of 
resistance arteries in congestive heart failure (CHF) is due to dysfunction of endothelium, 
there is very few study that a Rho associated protein kinase play a role of this enhance- 
ment of contractile response of resistance arteries in CHF. The aim of present study was 
to examine whether Ca2+ sensitivity is increase and to examine the role of Rho associ- 
ated protein kinase in activating contraction of resistance arteries in CHF. We also stud- 
ied the change in the response of protein kinase C (PKC) inhibitor in arteries in CHF 
compared with control. Methods and Results : Heart failure rat induced by ligation of the 
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isolated from rats were cannulated at a pressure of 40mmHg.Changes in internal diame- 
ter were examined with videomicroscopy. We tested the response dose-dependently to 
Y27632, a specific inhibitor for the Rho associated protein kinasa, in the presence of pre- 
contracted by PE. The precontraction of PE in CHF was significantly induced by low con- 
cantration than controls (10-7M vs 10-6M). The response to Y27632(10-7M, 3X10-6M, 
10-6M) of resistance arteries in CHF was more greater than that in controls(53% vs 
23%,70% vs 25%,89% vs 65%,respectively, P<0.01). Y27632 significantly inhibited PE- 
induced contraction in CHF compared with controls. PKC inhibitor had no significant 
effect on femoral arteries in both CHF and control. Conclusions.: The contraction of resis- 
tance arteries by PE were enhanced in CHF compaired with controls. Y27632 signifi- 
cantly inhibited phenylephrine-induced contraction in CHF.Enhancad Ca2+ sensitivity via 
a Rho kinasa-dependent pathway, but not PKC, may be involved enhanced contraction 
of resistance arteries by PE in CHE 
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1032-77 Prevention of Deep Venous Thrombosis on Long-Haul 
Flights 
Giovanni Belcaro. George Geroulakos, Mariateresa De Sanctis, Andrew N. Nicolaides, 
Lucrezia Incandela, Maria Rosada Cesarone, Marco Bucci, Andrew Lennox, Chieti 
Universi~ Pescara/San Valentino, Italy, St Mary's Hospital, London, United Kingdom. 
Background: the LONFLITI+2 studies have established that in high risk subjects after 
long (10-12 hours) flights the incidence of deep venous thrombosis (DVT) is between 4- 
6%. Methods: 400 subjects at high risk for DVT were randomisad into 4 groups to evalu- 
ate two types of prophylaxis in long-haul flights. The CONTROL GROUP: had no prophy- 
laxis; in the ASPIRIN TREATMENT GROUP subjects were treated with 400 mg (tablets) 
of aspirin, 1 dose daily for 3 days, starting 12 hours before the flight); in the LOW 
MOLECULAR WEIGHT HEPARtN (LMWH) GROUP, enoxapadne, one dose was 
injected between 2 and 4 hours before the flight. The dose was weight-adjusted, 1000 
LU. (O.1 ml) par 10 Kgs. in the fourth group prophylaxis was the combination of LMWH 
(dosage as in group 3) and graduated, below-knee stokings. Subjects with potential 
problems due to aspirin or LMWH or at risk of drugs interactions were excluded. 
RESULTS Out of the 100 included subjects in each group a total of 337 subjects com- 
pleted the study. Drop-outs due to low compliance or travelling/connections problems 
were 17%. Age and sex distribution were comparable in the three groups as well as risk 
distributions.. Mean age was 47 (range 28-75; SD 11; 65% males). CONTROL GROUP. 
Out of 82 subjects there were 4.8% of subjects with DV'I" (equivalent to 3.8% of limbs) 
with 2 superficial thromboses; 4.8% of limbs suffered for a thrombotic event. ASPIRIN 
GROUP (84 subjects) 3.6.% of patients had DV'I" (1.8% of limbs); there were 2 superficial 
thromboses (2.9% of limbs had a thrombotic event). In the LMWH group (82 subjects) 
there was no DVT. One superficial thrombosis was documented (0.61% of limbs had a 
thrombotic event) (P<0.002 in comparison with the previous two groups). In the 
LMWH+stockings group (88 subjects) there was no thrombotic event (P<0.002 in com- 
padson with the other groups). In this study 83% of DV'I's were in passengers in non-aisle 
seats. Mild side effects were observed (gastro-intestinal symptoms) in 13% of patients 
under aspirin. Considering these observations one-dose enoxaparin and elastic stock- 
ings are effective options in high-risk subjects, in long-haul flights. 
1032-78 Pulmonary Embolism Associated With Long Haul Air  
Travel 
Susan R. Hertzbero. Shiva Roy, Adam Chan, David Bdeger, Warren Walsh, Prince of 
Wales Hospital Sydney, Australia, St George Hospital, Sydney, Australia. 
BACKGROUND 
The association between long haul air travel and pulmonary embolism (PE) is recogn- 
ised, but the absolute risk has not been quantified. As Australia is geographically iso- 
lated, more than 50% of international travelers arrive at Sydney airport after a long haul 
flight. Patients who become unwell upon disembarkation are taken to one of the two hos- 
pitals in proximity to the airport. In this study we reviewed the presentations at these two 
hospitals in an attempt to quantify the risk of acute PE associated with long hau~ air 
travel. 
METHODS: A retrospective analysis of all patients presenting to the Emergency Depart- 
ments (ED) with PE over a three year period was undertaken and those patients admit- 
ted directly from Sydney's International airport were specifically examined. 
RESULTS: From January 1998 to January 2001, fifteen patients were admitted directly 
from Sydney's international airport to the ED with acute PE confirmed by pulmonary scin- 
tigraphy or spiral CT. All patients had flown for at least 9 hours, the majority had flown 14 
hours from Los Angeles. 
Eight of the nine patients with features of hemodynamic instability and/or right ventdcular 
dilatation received thrombolytic therapy and recovered well. The ninth patient suffered a 
cardiac arrest and died the day after presentation. The six remaining patients had an 
uncomplicated hospital course with conventional anticoagulant therapy. During the 
period of our review 6.6 million passengers arrived in Sydney on long haul international 
flights representing an incidence of 2.3 per million. 
CONCLUSION: The incidence of acute pulmonary embolism associated with long dis- 
tance air travel is low and the majority of patients survive following hospital presentation. 
1032-79 Deep Vein Thrombosis Is Frequent in Asymptomatic 
Patients Entering a Cardiac Rehabilitation Program 
After Coronary Artery Bypass Surgery 
Marco Ambrosetti. Mario Salerno, Mara Zambelli, Filippo Mastropasqua, Daniela 
Scrutinio, Roberto Tramadn, Roberto Pedrefti, S. Maugeri Foundation, Care and 
Research Institute, Tradate (VA), Italy. 
No specific guidelines on venous thromboprophylaxis after cardiac bypass (CABG) have 
been issued as in other surgical subspecialties. Few information are available about the 
prevalence of deep vein thrombosis (DVT) after discharge. 
Aims of this study were 1) to describe current DVT prophylaxis after CABG and 2) to esti- 
mate the rate of DVT in patients with a recent CABG entering a cardiac rehabilitation pro- 
gram. 
Two hundreds and seventy consecutive ambulating asymptomatic patients discharged 
from 19 surgery units (men 82%; mean age 65_+9 years, mean interval after operation 8 
days) underwent bilateral venous ultrasound examination (double-blind test performed 
by two operators) at admission in 3 rehabilitative institutions in Italy. Patients with previ- 
ous DVT or pulmonary embolism (PE), concomitant other cardiac surgery or planned 
anticoagulation were excluded. Testing was repeated 7 days later if the result was normal 
at admission and successively if symptoms occurred during hospitalization. 
31 patients (11%) received no pharmacological or mechanical prophylaxis despite 
absence of major contraindications. In 168 (62%) cases prophylaxis with subcutaneous 
heparin for more than 3 days after CABG or until discharge from surgery unit was 
present, while 102 (38%) cases were prescribed heparin for _<3 days. Graded compres- 
sion stockings (GCS) were prescribed in 76% of cases, bilaterally in 7%. 
DVT was detected in 47 (17.4%) patients, complicated in 2 (0.7%) by symptomatic PE (1 
fatal PE). Proximal DVT was detected in 7 cases (2.6%), while distal DVT accounted for 
remaining 40 (14.8%). In 23 cases (49%), clots were found in the leg contralateral to the 
saphenous vein harvest site. On multivariate analysis the following variables were inde- 
pendently associated with major risk of DVT after CABG: female sex (p<O.001), length of 
stay in surgery unit >8 days (p<0.05) and absence of heparin prophylaxis (p<0.05). 
This study showed a high rate of DVT in ambulating asymptomatic patients admitted to a 
cardiac rehabilitation program after CABG. Wearing monolateral GCS after CABG had 
limited efficacy, as clots were often localized bilaterally. The role of routine heparin pro- 
phylaxis should be extensively investigated. 
1032-80 Is Troponin I a Risk Factor for Poor Outcome in 
Pulmonary Embolism? 
Aimae E. Koraleskv. Bradley Bart, Fred Apple, Timothy D. Henry, Hennepin County 
Medical Center, Minneapolis, Minnesota, University of Minnesota, Minneapolis, 
Minnesota. 
Background: Three small trials have reported a wide range of increased cardiac biomar- 
kers in acute pulmonary embolism (PE): 7.7% CK-MB, 32% troponin T, and 39% troponin 
I (TI). Elevated troponins may be predictive of mortality, right ventricular dysfunction 
(RVD) and poor outcome. RVD has been shown to be a predictor of mortality. We 
reviewed 135 patients (pts) with a confirmed diagnosis of PE in which TI and echocardio- 
grams had been obtained to determine whether TI is a predictor of mortality and poor 
outcome. Various cutoffs of TI positivity were examined to determine the best positive 
predictive value. In addition, RVD was assessed as a risk factor for mortality and poor 
outcome. RVD and TI were compared to determine which is the stronger predictor. 
Methods: 135 consecutive pts with documented PE and TI were identified. 98 pts under- 
went echocardiography during their hospitalization. RVD was defined by RV hypokinesis, 
RV enlargement, or right-sided prominence. In addition to in-hospital death, a poor out- 
come was defined as hemodynamic instability resulting in use of pressors, need for intu- 
bation, or recurrent PE. 
Results: Of the 135 pts, 26 pts died, representing an overall 19% in-hospital mortality 
rate, 24% of pts had peak TI > 0.7 ng/mL, 47% had peak TI _> 0.3 ng/mL, and 53% had 
peak TI > 0.1 ng/mL. TI levels _> 0.7 ng/mL, 0.3 ng/mL, and 0.1 ng/mL resulted in positive 
predictive values of 38%, 25%, and 25% for mortality, respectively (RR 2.97, 1.83, 1.97). 
Negative predictive values for mortality were 87%, 87%, and 86%. Poor outcome 
occurred in 56%, 46%, and 43% (RR 1.7, 1.44, 1.29). In contrast, pts with RVD, regard- 
less of TI, had a 22% mortality rate and poor outcome in 40% (RR 0.89, 0.94). Pts with TI 
> 0.7 had a significant increase in mortality (p < 0.005) and poor outcomes (p < 0.03) but 
TI >_ 0.3, >0.1, and RVD were not significant. TI >_ 0.7 was more often associated with 
death than was RVD (p = 0.125). 
Conclusions: Elevated TI is a predictor of death and poor outcome in PE. A cutoff of 0.7 
ng/mL is more predictive than lower values. TI positivity may be a better predictor of poor 
outcome or death than is RVD. These results have implications for therapeutic options 
such as thrombolytic therapy and should be tested by prospective trials. 
1032-81 Prognostic Significance of Elevated Tropon in  I in Acute 
Pulmonary Embolism 
John A. Sallach. Susan M Sallach, Michael P. Hudson, Mei Lu, James K. McCord, Henry 
Ford Heart and Vascular Institute, Detroit, Michigan. 
Background: Prior studies demonstrate that troponin I (cTnl) and T, sensitive and specific 
markers of cardiac injury, are elevated in some cases of pulmonary embolism (PE). -('he 
purpose of this study was to determine the prognostic significance of elevated cTnl in 
acute PE. 
Methods: Between 1998 and 2000, 287 patients presented to a US tertiary center with 
acute PE diagnosed by VQ scan, spiral CT or pulmonary angiogram. Of these, 177 
(61.7%) had cTnl measured within 24 hours of PE diagnosis using the AxSYM cTnl 
immunoassay (upper limit of normal = 1.0 ng/mL; Abbott Labs). Baseline characteristics 
and outcomes were compared between patients with elevated vs. normal cTnl levels 
using univariate analysis and multivariable adjustment for possible confounders. 
